Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

AXIN-1 protein expression and localization in glioblastoma.

Pećina-Slaus N, Martić TN, Kokotović T, Kusec V, Tomas D, Hrasćan R.

Coll Antropol. 2011 Jan;35 Suppl 1:101-6.

PMID:
21648318
2.

Changes of AXIN-1 and beta-catenin in neuroepithelial brain tumors.

Nikuseva Martić T, Pećina-Slaus N, Kusec V, Kokotović T, Musinović H, Tomas D, Zeljko M.

Pathol Oncol Res. 2010 Mar;16(1):75-9. doi: 10.1007/s12253-009-9190-9. Epub 2009 Jul 25.

PMID:
19633924
3.

Disabled-2 and Axin are concurrently colocalized and underexpressed in lung cancers.

Xu HT, Yang LH, Li QC, Liu SL, Liu D, Xie XM, Wang EH.

Hum Pathol. 2011 Oct;42(10):1491-8. doi: 10.1016/j.humpath.2011.01.004. Epub 2011 Apr 14.

PMID:
21496867
4.

Axin induces cell death and reduces cell proliferation in astrocytoma by activating the p53 pathway.

Zhang LY, Ye J, Zhang F, Li FF, Li H, Gu Y, Liu F, Chen GS, Li Q.

Int J Oncol. 2009 Jul;35(1):25-32.

PMID:
19513548
5.

The trimeric G protein Go inflicts a double impact on axin in the Wnt/frizzled signaling pathway.

Egger-Adam D, Katanaev VL.

Dev Dyn. 2010 Jan;239(1):168-83. doi: 10.1002/dvdy.22060.

6.

AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.

Li Q, He Y, Wei L, Wu X, Wu D, Lin S, Wang Z, Ye Z, Lin SC.

Oncogene. 2011 Mar 10;30(10):1194-204. doi: 10.1038/onc.2010.499. Epub 2010 Nov 8.

PMID:
21057547
7.

Atonal homolog 1 expression in lung cancer correlates with inhibitors of the Wnt pathway as well as the differentiation and primary tumor stage.

Xu HT, Xie XM, Li QC, Liu SL, Dai SD, Liu Y, Wang EH.

APMIS. 2013 Feb;121(2):111-9. doi: 10.1111/j.1600-0463.2012.02946.x. Epub 2012 Jul 4.

PMID:
23030416
8.
9.

Daxx cooperates with the Axin/HIPK2/p53 complex to induce cell death.

Li Q, Wang X, Wu X, Rui Y, Liu W, Wang J, Wang X, Liou YC, Ye Z, Lin SC.

Cancer Res. 2007 Jan 1;67(1):66-74.

10.

Aberrant nuclear localization of beta-catenin without genetic alterations in beta-catenin or Axin genes in esophageal cancer.

Kudo J, Nishiwaki T, Haruki N, Ishiguro H, Shibata Y, Terashita Y, Sugiura H, Shinoda N, Kimura M, Kuwabara Y, Fujii Y.

World J Surg Oncol. 2007 Feb 19;5:21.

11.

X-radiation induces non-small-cell lung cancer apoptosis by upregulation of Axin expression.

Han Y, Wang Y, Xu HT, Yang LH, Wei Q, Liu Y, Zhang Y, Zhao Y, Dai SD, Miao Y, Yu JH, Zhang JY, Li G, Yuan XM, Wang EH.

Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):518-26. doi: 10.1016/j.ijrobp.2009.05.040.

PMID:
19735876
12.

Reduced axin protein expression is associated with a poor prognosis in patients with squamous cell carcinoma of esophagus.

Li AF, Hsu PK, Tzao C, Wang YC, Hung IC, Huang MH, Hsu HS.

Ann Surg Oncol. 2009 Sep;16(9):2486-93. doi: 10.1245/s10434-009-0593-3. Epub 2009 Jul 7.

PMID:
19582507
13.

Sequence variants of the axin gene in breast, colon, and other cancers: an analysis of mutations that interfere with GSK3 binding.

Webster MT, Rozycka M, Sara E, Davis E, Smalley M, Young N, Dale TC, Wooster R.

Genes Chromosomes Cancer. 2000 Aug;28(4):443-53.

PMID:
10862053
14.

Overexpression of axin downregulates TCF-4 and inhibits the development of lung cancer.

Xu HT, Wei Q, Liu Y, Yang LH, Dai SD, Han Y, Yu JH, Liu N, Wang EH.

Ann Surg Oncol. 2007 Nov;14(11):3251-9. Epub 2007 Sep 1.

PMID:
17768662
15.

Methylation by protein arginine methyltransferase 1 increases stability of Axin, a negative regulator of Wnt signaling.

Cha B, Kim W, Kim YK, Hwang BN, Park SY, Yoon JW, Park WS, Cho JW, Bedford MT, Jho EH.

Oncogene. 2011 May 19;30(20):2379-89. doi: 10.1038/onc.2010.610. Epub 2011 Jan 17.

PMID:
21242974
16.
17.
18.

Nucleo-cytoplasmic shuttling of Axin, a negative regulator of the Wnt-beta-catenin Pathway.

Wiechens N, Heinle K, Englmeier L, Schohl A, Fagotto F.

J Biol Chem. 2004 Feb 13;279(7):5263-7. Epub 2003 Nov 20.

20.

Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.

Santosh V, Arivazhagan A, Sreekanthreddy P, Srinivasan H, Thota B, Srividya MR, Vrinda M, Sridevi S, Shailaja BC, Samuel C, Prasanna KV, Thennarasu K, Balasubramaniam A, Chandramouli BA, Hegde AS, Somasundaram K, Kondaiah P, Rao MR.

Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1399-408. doi: 10.1158/1055-9965.EPI-09-1213. Epub 2010 May 25.

Items per page

Supplemental Content

Write to the Help Desk